The stock runs up from here to $3.00 by the time May 8th Conference Call. SQNM releases record revenues and beats street estimates handily pointing the way clearly that breakeven will happen 4th quarter maybe even 3rd quarter. Stock jumps 33% next day to $4.00 and maintains that level as upgrades trickle in. In the 2nd quarter, FDA approval is announced and speculation of BioScience division sale feeds share price up to $6-$7 area. In third quarter company announces sale of Bio Science division for between $150-$300 million, stock fires up to $10/share heading toward CAFC hearing in late Oct/Early Nov. SQNM reaches positive cash flow in 4th quarter and the '540 patent is upheld by Judge Radar. We immediately double to $20.00. Numerous analyst upgrades stream in and SQNM announces new Low/Medium Risk test. Throughout the course of 2015 the stock has a steady climb from $20 up to $40 where we get a buyout offer anywhere from $50 to $60.
How does that sound?? pretty realistic to me if all things fall into place.